Litcius/Paper detail

Deletion of RBMX RGG/RG motif in Shashi-XLID syndrome leads to aberrant p53 activation and neuronal differentiation defects

Ting Cai, Jessica Cinkornpumin, Zhenbao Yu, Oscar D. Villarreal, William A. Pastor, Stéphane Richard

2021Cell Reports29 citationsDOIOpen Access PDF

Abstract

RNA-binding proteins play important roles in X-linked intellectual disability (XLID). In this study, we investigate the contribution of the XLID-associated RBMX in neuronal differentiation. We show that RBMX-depleted cells exhibit aberrant activation of the p53 pathway. Moreover, we identify that the RBMX RGG/RG motif is methylated by protein arginine methyltransferase 5 (PRMT5), and this regulates assembly with the SRSF1 splicing factor into higher-order complexes. Depletion of RBMX or disruption of the RBMX/SRSF1 complex in PRMT5-depleted cells reduces SRSF1 binding to the MDM4 precursor (pre-)mRNA, leading to exon 6 exclusion and lower MDM4 protein levels. Transcriptomic analysis of isogenic Shashi-XLID human-induced pluripotent stem cells (hiPSCs) generated using CRISPR-Cas9 reveals a dysregulation of MDM4 splicing and aberrant p53 upregulation. Shashi-XLID neural progenitor cells (NPCs) display differentiation and morphological abnormalities accompanied with excessive apoptosis. Our findings identify RBMX as a regulator of SRSF1 and the p53 pathway, suggesting that the loss of function of the RBMX RGG/RG motif is the cause of Shashi-XLID syndrome.

Topics & Concepts

BiologyCell biologyRNA splicingInduced pluripotent stem cellRNA-binding proteinExonDownregulation and upregulationAlternative splicingHEK 293 cellsProtein arginine methyltransferase 5TranscriptomeGeneticsRNAEmbryonic stem cellMethyltransferaseMethylationGeneGene expressionCancer-related gene regulationGenetics and Neurodevelopmental DisordersRNA modifications and cancer